The Key Laboratory of Geriatrics, Beijing Hospital & Beijing Institute of Geriatrics, Ministry of Health, Beijing 100730, China.
Acta Pharmacol Sin. 2013 Nov;34(11):1449-56. doi: 10.1038/aps.2013.123. Epub 2013 Sep 30.
Cytochrome P450 2C9 (CYP2C9) is a polymorphic enzyme that is responsible for the metabolism of approximately 15% of clinically important drugs. The aim of this study was to assess the catalytic characteristics of 37 CYP2C9 allelic isoforms found in Chinese Han population on the metabolism of tolbutamide in vitro.
The wild-type and 36 CYP2C9 variants were expressed in sf21 insect cells using a baculovirus-mediated expression system. Then the insect microsomes were prepared for assessing the metabolic characteristics of each variant toward the CYP2C9-specific drug substrate tolbutamide.
Of 36 allelic variants tested, the intrinsic clearance values of 2 allelic isoforms (CYP2C9.36 and CYP2C9.51) were much higher than the wild-type CYP2C9.1 protein, 3 allelic isoforms (CYP2C9.11, CYP2C9.56 and N418T) exhibited similar intrinsic clearance values as the wild-type enzyme, whereas the other 31 variants showed significantly reduced intrinsic clearance values, ranging from 0.08% to 66.88%, for tolbutamide.
Our study provides the most comprehensive data concerning the enzymatic activity of the CYP2C9 variants that are present in the Chinese Han population, and our data suggest that most of the carriers of these alleles might be paid more attention when using CYP2C9 mediated drugs clinically.
细胞色素 P450 2C9(CYP2C9)是一种多态性酶,负责代谢约 15%的临床重要药物。本研究旨在评估中国汉族人群中发现的 37 种 CYP2C9 等位基因变异体对体外甲苯磺丁脲代谢的催化特性。
使用杆状病毒介导的表达系统在 sf21 昆虫细胞中表达野生型和 36 种 CYP2C9 变体。然后制备昆虫微粒体,以评估每种变体对 CYP2C9 特异性药物底物甲苯磺丁脲的代谢特征。
在所测试的 36 种等位基因变异体中,2 种等位基因变异体(CYP2C9.36 和 CYP2C9.51)的内在清除率值明显高于野生型 CYP2C9.1 蛋白,3 种等位基因变异体(CYP2C9.11、CYP2C9.56 和 N418T)的内在清除率值与野生型酶相似,而其他 31 种变异体的内在清除率值明显降低,范围为 0.08%至 66.88%,用于甲苯磺丁脲。
我们的研究提供了关于中国汉族人群中存在的 CYP2C9 变异体酶活性的最全面数据,我们的数据表明,在临床上使用 CYP2C9 介导的药物时,这些等位基因的大多数携带者可能需要更多的关注。